CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed
Drug / intervention
laparoscopic surgery +2 moreprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00019955
NCT00019955Phase 2Completed
CompareCT.gov

A Phase II Study to Evaluate Radiofrequency Ablation of Renal Cancer

National Cancer Institute (NCI)·interventional·Posted Jan 27, 2003·Updated Apr 29, 2015

In Brief

A Phase 2 clinical trial evaluating laparoscopic surgery, radiofrequency ablation, and 1 other intervention for Kidney Cancer. Completed, across 1 site.

Detailed Summary

RATIONALE: Radiofrequency interstitial tissue ablation may kill tumor cells by heating tumors to several degrees above body temperature. PURPOSE: This phase II trial is studying radiofrequency interstitial tissue ablation to see how well it works in treating patients with localized renal cell carcinoma (kidney cancer).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsKidney Cancer
CountriesUnited States
Collaborators--

Timeline

Phase 2CompletedFinished
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJan 27, 2003
Enrollment StartMar 1, 2000
TodayJul 2, 2026
Posted 23.4 years ago

Interventions

laparoscopic surgeryprocedure

radiofrequency ablationprocedure

thermal ablation therapyprocedure